Health

Veeva-Salesforce split: A catalyst for commercial transformation in life sciences

Life sciences companies can turn a forced choice into a strategic opportunity to revolutionize healthcare professional (HCP) engagement

The Veeva–Salesforce split is forcing a decision for nearly every life sciences company — but it’s also opening the door to something bigger. In this point of view, we explore how this moment can spark a true transformation in HCP engagement, driven by smarter CRM strategy and emerging technologies.

Request a copy of our PoV to see how you can turn a forced choice into a strategic opportunity.

Use right arrow keys to slide, or drag right with your finger. When you reach 100 percent, the form is submitted.

We are sorry, the form submission failed. Please try again.